Guy Chung‐Faye

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Nicholas A. Kennedy, Graham Heap, Harry Green et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 677 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease

Aleksejs Sazonovs, Nicholas A. Kennedy, Loukas Moutsianas et al. · Gastroenterology · 2019 · 409 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience

Sailish Honap, Desmond Chee, Thomas Chapman et al. · Journal of Crohn s and Colitis · 2020 · 123 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study

Neil Chanchlani, Simeng Lin, Claire Bewshea et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 123 citations · Full text

Medicine, Clinical Sciences, Immunology +17

Fecal M2-pyruvate kinase (M2-PK): A novel marker of intestinal inflammation

Guy Chung‐Faye, Bu Hayee, Susan Maestranzi et al. · Inflammatory Bowel Diseases · 2007 · 92 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17